Symmetry
® C18 (4.6 x 150 mm, 5 µm) reverse-phase HPLC column. For mass spectrometry in negative mode (compounds 6 and 7), mobile phase was solvent A = TEAA 10 mM, pH 7 and solvent B = absolute MeOH, the gradient was 0 to 70% B over 35 min, flow rate was 0.5 ml/min, capillary voltage was -3317V, and sample cone voltage was -50V. For mass spectrometry in positive mode (compound 4), mobile phase was solvent A = H 2 O + 0.1% formic acid, solvent B = CH 3 CN + 0.1% formic acid, the gradient was 0 to 15% B over 20 min, flow rate was 0.5 ml/min, capillary voltage was -3317V, and sample cone voltage was -50V.
NMR Spectroscopy: NMR spectra were recorded on a Varian 400 MHz NMR system. Chemical shifts, δ, are represented in part per million (ppm) and coupling constants, J, in Hertz (Hz). Tetramethylsilane (TMS, 0 ppm) was used as the internal standard for proton NMR and 85% orthophosphoric acid was used as the internal standard for phosphorus NMR.
Intraoperative NIR Fluorescence Imaging System: The principles of the optical path were published in detail previously. [1, 2] Briefly, a zoom lens with a working distance of 18" directs light to a dichroic mirror, where the visible light (400-700 nm) is deflected to a color video camera (Imitech IMC-80F, IMI Technology Co., Seoul, Korea), and the NIR fluorescence light (> 785 nm) is filtered by an emission filter (> 795 nm longpass filter) prior to reaching an NIR sensitive camera (Orca-AG, Hamamatsu, Bridgewater, NJ, USA). The entire optical system is mounted on a shock-resistant aluminum frame, enclosed by a sealed cover measuring 12"W x 12"H x 9"D, and mounted on an adjustable arm that swings out over the surgical field.
NIR excitation light is provided by an array of 10 high-powered (1W) light emitting diodes (LEDs; L -760-66-60, Marubeni Epitex, New York, NY, USA), which are filtered (HHQ750/50x, Chroma Technology, Brattleboro, VT, USA) and focused on the surgical field. White light is provided by an array of four Luxeon III white light diodes (Lumileds, San Jose, CA, USA) from which all NIR wavelengths are filtered out (filter E680SP, Chroma). The generated fluence rates for NIR excitation and white light range from 0-5 mW/cm 2 and 0-1 mW/cm 2 , respectively. Spatial resolution at a field-of-view of 20 x 15 cm is 625 µm, and at a field-of-view of 4 x 3 cm is 125 µm. After computer-controlled (LabVIEW) camera acquisition via custom LabVIEW (National Instruments, Austin, TX) software, anatomic (white light) and functional (NIR fluorescence light) images can be displayed separately and merged. To create a single image that displays both anatomy (color video) and function (NIR fluorescence), the NIR fluorescence image is pseudo-colored in lime green and overlaid with 100% transparency on top of the color video image of the same surgical field. All images are refreshed up to 15 times per second. The entire apparatus is suspended on an articulated arm over the surgical field, thus permitting non-invasive and non-intrusive imaging. Hands-free operation utilizing motorized zoom and focus lenses, a four-pedal footswitch, and a multifunction data acquisition board were described in detail previously. [3] 
Detailed Procedures
Synthesis of 3-amino-propionyl chloride 2: Thionyl chloride (1.46 mL, 20 mmol) was added slowly at 0°C to the suspension of 3-amino-propionic acid (0.89 g, 10 mmol) in CH 2 Cl 2 (25 mL). After 10 min, the ice bath was removed and the mixture was heated at reflux for 1 h. The reaction mixture was concentrated under reduced pressure and distilled to give 3-amino-propionyl chloride 2 (1.07g, ~99%). 1 H NMR (400 MHz, CD 3 OD) δ 2.20 (brs, 2H), 2.79 (t, J=6.6 Hz, 2H), 3.22 (t, J=6.2 Hz, 2H).
Synthesis of 3-amino tetramethyl 1-hydroxypropylidenebisphosphonate 4a: To 3-aminopropionyl chloride 2 (1.07 g, 10 mmol) at 0°C, was added trimethylphosphite (1.18 mL, 10 mmol) over a period of 5 min with stirring under a nitrogen atmosphere. After 10 min, the ice bath was removed and stirring was continued at room temperature (RT) for 30 min to obtain an intermediate 3-amino-dimethyl propionylphosphonate 3. The reaction mixture was again cooled to 0°C and dimethylphosphite (0.92 mL, 10 mmol) was added over a period of 5 min with stirring under a nitrogen atmosphere. The ice bath was removed after 10 min and stirring was continued at RT for 30 min. The reaction mixture was concentrated under vacuum and purified by flash chromatography/HPLC. In flash chromatography, Dittmer's reagents was used for TLC visualization and ethyl acetate-methanol (4:1) solvent system as an eluant to give viscous colorless liquid compound 4a (2.63 g, 91%). The product was analyzed by LCMS and NMR. For LCMS, H 2 O and CH 3 CN, both with 0.1% formic acid, were used as solvents A and B, respectively. Using a linear gradient from 0 to 15% B over 20 min, at a flow rate of 0.5 mL/min, compound 4a was detected at 5.9 min. added at 0°C under nitrogen atmosphere to the methylester-protected pamidronate 4a (0.73 mg, 2.5 µmol) taken in dry DMSO (0.05 mL). The vortexing continued for 4 h at RT in the dark. The reaction mixture was poured over 0.4 mL ice-cold water and purified by reverse-phase HPLC using a Symmetry Prep ® C 18 column (19 x 150 mm, 7 µm particle size) and a dual-wavelength absorbance detector (set to 254 and 700 nm). Solvent A was 10 mM TEAA and solvent B was absolute CH 3 OH. The purification utilized a linear gradient from 0% to 70% solvent B over 35 min, beginning 5 min after injection. Mobile phase flow rate was 15 mL/min. Compound eluted with a retention time of 26 min from the start of the gradient was collected. After concentration on an Oasis HLB desalting cartridge (Waters) and subsequent lyophilization a bright green solid reaction component termed Pam800 methyl ester 6a was obtained (2.55 mg, 80%). The product was characterized by LCMS and NMR. Using LCMS with the same solvent system as (6a, HPLC) above, with a flow rate of 0.5 ml/min and a linear gradient from 0% to 70% in 35 min, compound 6a was observed at a retention time of 24.1 min. In 31 P NMR, Pam800 methyl ester 6a showed a single peak at 21.52 ppm due to two equivalent phosphorus atoms, while the undesired phosphate phosphonate isomer 6b showed two equal peaks at 0.17 and 21.97 ppm due to two non-equivalent phosphorus atoms. 
Spectral Measurements:
Absorbance spectroscopy was performed in a 1 cm path length quartz cuvette (Starna, Atascadero, CA, USA), mounted in a CUV-ALL-UV four-way cuvette holder (Ocean Optics, Dunedin, FL, USA), and excited with a balanced deuterium-tungsten light source (Ocean Optics) spectrometer with a 1.3 nm resolution from 200 to 850 nm, using 2 µM of NIR fluorophore in the indicated buffer. Fluorescence spectrometry was performed in a three-sided quartz cuvette (Starna) excited with a 5 mW 770 nm laser diode coupled through a 300 µm core diameter, NA 0.22 fiber (Fiberguide Industries, Stirling, NJ, USA). Fluorescence measurements were made on an HR2000 (Ocean Optics) spectrometer with a 7.6 nm resolution from 350 to 1000 nm, using 2 µM NIR fluorophore in the indicated buffer. QYs of Pam800 in PBS, pH 7.4 or 100% fetal bovine serum were calculated using ICG in DMSO (QY 13% [4] ) as calibration standard, under conditions of matched fluorophore absorbance at the 770 nm laser line and compared with the parent dye, i.e., IRDye ® 800CW carboxylic acid. [5] Comparison of the two fluorophores is as follows:
Extinction Coefficient (M In Vitro Calcium Salt Specificity Experiments and NIR Fluorescence Microscopy: 5 mg/mL of hydroxyapatite (HA) or the phosphate, oxalate, carbonate, and pyrophosphate salts of calcium were separately incubated with 100 nM Pam800 in 100 µL PBS for 30 min with continuous vortexing at RT. Crystals were washed 4 times with a 100-fold excess of PBS, centrifuged and visualized using the previously described NIR fluorescence imaging system at a fluence rate of 5 mW/cm 2 . All NIR fluorescence images had identical exposure times and normalizations. The same crystals were also mounted on plane glass slide and viewed under a Nikon Eclipse TE-300 epi-fluorescence microscope equipped with a 100 W mercury light source, NIRcompatible optics, and a NIR-compatible 10X PlanFluor objective lens (model 93171; Nikon, Melville, NY, USA). A custom NIR filter set (Chroma Technology Corporation, Brattleboro, VT, USA) was composed of a 750±25 nm excitation filter, a 785 nm dichroic mirror, and an 810±20 nm emission filter. Images were acquired on an Orca-ER (Hamamatsu, Bridgewater, NJ, USA Hamamatsu). Image acquisition and analysis was performed using IPLab s oftware (Scanalytics, Fairfax, VA, USA). All NIR fluorescence images had identical exposure times and normalizations.
In control experiments, there was no detectable binding of IRDye ® 800CW carboxylic acid to any of the calcium salts. Also, the possibility of fluorescence quenching of Pam800 leading to a false-negative result with non-HA salts was ruled out because absorbance measurements of the supernatant confirmed complete recovery of unbound dye. Pam800 (7) and its phosphate phosphonate isomer derived from 4b or 6b were compared for in vitro HA binding. Pam800 demonstrated approximately two-fold stronger HA binding than its isomer, and was therefore used for all in vivo experiments.
Detection of HA-Containing Calcifications in the Living Animal Using in vivo NIR Fluorescence Imaging: Twenty minutes before Pam800 injection, individual 10 mg/mL suspensions of 100 µm (HA) or calcium oxalate crystals were prepared in PBS. In a 30 kg Yorkshire pig model, a total of 0.5 mL (5 mg of solid) of these suspensions were injected subcutaneously around the nipples with a 21-gauge needle. 0.06 µmol/kg (1.8 mg total) of Pam800 in 20 mL saline was administered via the left external jugular vein. Pigs were imaged every 15 min for the first hour, then every hour for the next 3 h after Pam800 injection.
